Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

The irreversibly sickled cell: a perspective.

¹The Sickle Cell Disease Research Center, The Institute of Biomedical Sciences and Technology, The University of Texas at Dallas, Richardson, Texas 75083, USA. sgoodmn@utdalles.edu

Cellular and Molecular Biology (Noisy-Le-Grand, France)

|March 26, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

An equilibrium-point model of electromyographic patterns during single-joint movements based on experimentally reconstructed control signals.

Journal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology·2010

Same author

Spectrin and ubiquitination: a review.

Cellular and molecular biology (Noisy-le-Grand, France)·2006

Same author

Erythrocyte spectrin's chimeric E2/E3 ubiquitin conjugating/ligating activity.

Cellular and molecular biology (Noisy-le-Grand, France)·2005

Same author

Complications with 25-gauge and 27-gauge Whitacre needles during combined spinal-epidural analgesia in labor.

International journal of obstetric anesthesia·2004

Same author

Band 3 is a target protein of spectrin's E2/E3 activity: implication for sickle cell disease and normal red blood cell aging.

Cellular and molecular biology (Noisy-le-Grand, France)·2004

Same author

Preface: Thematic issue on sickle cell disease.

Cellular and molecular biology (Noisy-le-Grand, France)·2004

Same journal

Differential effects of high-sucrose and high-fat diets on metabolic syndrome, BBB integrity, and hippocampal Aβ accumulation.

Cellular and molecular biology (Noisy-le-Grand, France)·2026

Same journal

CRISPR systems in cancer therapeutics and diagnostics.

Cellular and molecular biology (Noisy-le-Grand, France)·2026

Same journal

Sex-specific effects of fluoxetine on REM sleep deprivation-induced behavioral impairments and BDNF downregulation in rats.

Cellular and molecular biology (Noisy-le-Grand, France)·2026

Same journal

Gene polymorphism and serum level of RANKL among patients with rheumatoid arthritis: a systematic review and meta-analysis.

Cellular and molecular biology (Noisy-le-Grand, France)·2026

Same journal

Effect of peniocerol on human meniscal fibrochondrocyte inflammation induced by IL-1β and TNF-α through the NF-κB signaling pathway.

Cellular and molecular biology (Noisy-le-Grand, France)·2026

Same journal

Integrated density functional theory, molecular docking, and pharmacokinetic modeling of mukonal and its derivatives as inhibitors of the Plasmodium falciparum TFIIH complex (Tfb5 subunit).

Cellular and molecular biology (Noisy-le-Grand, France)·2026

See all related articles

N-acetylcysteine (NAC) reduces irreversibly sickled cells (ISCs) by preventing oxidative damage and promoting membrane skeleton disassembly. This antioxidant therapy shows promise in decreasing dense cells and vaso-occlusive crises in sickle cell disease patients.

Area of Science:

Hematology
Biochemistry
Cell Biology

Background:

Irreversibly sickled cells (ISCs) are dehydrated, poorly deformable, and contribute to vaso-occlusive episodes in sickle cell disease.
Oxidative stress and altered redox status in sickle cells lead to protein damage, including glutathiolation and impaired ubiquitination.
Damage to beta-actin and alpha-spectrin results in a "locked" membrane skeleton that cannot disassemble, exacerbating ISC pathology.

Purpose of the Study:

To investigate the molecular mechanisms underlying ISC formation and the potential therapeutic effects of N-acetylcysteine (NAC).
To examine how oxidative damage affects key proteins like beta-actin and spectrin in ISCs.
To evaluate NAC's efficacy in preventing ISC formation and reducing vaso-occlusive crises.

Main Methods:

Related Experiment Videos

Analysis of redox status and oxygen radical levels in high-density sickle cells.
Investigation of disulfide bridge formation in beta-actin and glutathiolation in spectrin.
Assessment of ubiquitination status of alpha-spectrin and the resulting spectrin-4.1-actin complex affinity.
In vitro studies using N-acetylcysteine (NAC) to block ISC formation.
Review of a Phase II human trial assessing NAC's impact on ISCs, dense cells, and vaso-occlusive episodes.

Main Results:

Oxidative damage leads to beta-actin glutathiolation and impaired depolymerization, while spectrin glutathiolation inhibits its ubiquitination.
Loss of alpha-spectrin ubiquitination increases the affinity of the spectrin-4.1-actin complex, locking the membrane skeleton.
NAC, an antioxidant, effectively raises glutathione levels and inhibits ISC formation in vitro.
A Phase II trial indicated NAC reduced ISC counts, significantly decreased dense cells, and substantially lowered VOC episode rates.

Conclusions:

Reversible oxidative damage to beta-actin and impaired alpha-spectrin ubiquitination create a "locked" ISC membrane skeleton, contributing to sickle cell pathophysiology.
N-acetylcysteine (NAC) demonstrates potential as a therapeutic agent by mitigating oxidative stress and improving red blood cell properties.
NAC's ability to reduce ISCs, dense cells, and VOC episodes warrants further investigation in larger clinical trials for sickle cell disease management.